Position in CELU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,764
-$13,176 QoQ
Shares Held
18,000
0.0% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 39 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. CELU ranks #277 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in CELU
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,764 | 18,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $23,940 | 18,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,980 | 18,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,260 | 18,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $79,380 | 40,500 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $104,665 | 60,500 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $46,800 | 22,500 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $66,825 | 22,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $71,448 | 22,827 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $117,675 | 22,500 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $55,575 | 225,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $50,890 | 229,235 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $119,925 | 225,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $141,719 | 228,581 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,793 | 13,019 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,307 | 2,298 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $299 | 88 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,350 | 1,418 | Shares | Defined | 2022-05-16 | |
| 2020-12-31 GXGX | — | 350 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 GXGX | — | 98 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 GXGX | — | 1,000 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||